Among 245 adolescents seeking treatment for chronic pain, 25% reported cannabis use, with 77% of users saying they used it specifically to manage pain, sleep, or anxiety symptoms.
Pediatric pain specialists, adolescent medicine physicians, parents of teens with chronic pain
25% of teens in pain treatment use cannabis; 77% for symptom relief
What the researchers found
25.3% of treatment-seeking adolescents with chronic pain reported lifetime cannabis use (mean first use age 15.3). Among users, 77.4% endorsed instrumental use to manage symptoms (primarily pain, sleep, anxiety). Cannabis users had higher pain interference (mean difference 2.7, p = 0.01) and depressive symptoms (difference 6.2, p < 0.001). Non-users perceived cannabis as significantly riskier (OR 2.37, p = 0.01).
Why it matters
A quarter of teens in pain treatment are using cannabis, mostly to self-treat their condition. This represents a large unaddressed clinical reality where patients are supplementing or substituting formal treatment with cannabis despite limited evidence for its efficacy in pediatric pain.
The numbers in context
245 adolescents; 25.3% lifetime cannabis use; mean first use 15.3 years; 77.4% instrumental use; past-year 90.2% of users; past-month 64.5%; higher pain interference (p = 0.01) and depression (p < 0.001) in users.
How the study worked
Cross-sectional survey of 245 adolescents (mean age 16.9, 69% female) at a pediatric pain clinic (September 2021-May 2024). Validated self-report measures of pain, substance use, and risk perceptions. Published in JAMA Network Open.
What this study cannot tell us
Cross-sectional design cannot determine whether cannabis use preceded or followed pain worsening. Single pediatric pain center. Self-reported cannabis use may be underestimated in an adolescent clinical setting. Treatment-seeking population may not represent all teens with chronic pain.
How to read the evidence
Well-designed cross-sectional study published in JAMA Network Open with validated measures, limited by single center and cross-sectional design.
When this study was published
2025 publication with 2021-2024 data
The bigger picture
Published in JAMA Network Open, this study highlights a disconnect between patient behavior and clinical guidance. Most pediatric pain specialists would not recommend cannabis, yet a quarter of their patients are already using it for symptom management.
Questions still open
- Does instrumental cannabis use by teens with chronic pain improve or worsen long-term outcomes?
- How should clinicians address cannabis self-medication in adolescent pain patients?
Common questions
Do teens with chronic pain use cannabis?
Does cannabis help teens with chronic pain?
Read the original research
Prevalence Rates, Perceptions of Risk, and Motivations for Nonmedical Cannabis Use in Pediatric Pain.
JAMA network open, 8(5), e2512870
Citation
Kossowsky, Joe; Greco, Christine; Nestor, Bridget A; Koike, Camila; Tacugue, Nicole; Baumer, Andreas M; Weitzman, Elissa R. (2025). Prevalence Rates, Perceptions of Risk, and Motivations for Nonmedical Cannabis Use in Pediatric Pain.. JAMA network open, 8(5), e2512870. https://doi.org/10.1001/jamanetworkopen.2025.12870
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk